| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 16:29:51 UTC |
|---|
| Update Date | 2021-09-26 23:11:39 UTC |
|---|
| HMDB ID | HMDB0256177 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan |
|---|
| Description | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Based on a literature review very few articles have been published on N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-((hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O)C=C1)C(O)=O InChI=1S/C34H45N5O6/c1-22(2)18-27(37-34(45)39-16-8-4-5-9-17-39)31(41)35-28(20-24-21-38(3)30-11-7-6-10-26(24)30)32(42)36-29(33(43)44)19-23-12-14-25(40)15-13-23/h6-7,10-15,21-22,27-29,40H,4-5,8-9,16-20H2,1-3H3,(H,35,41)(H,36,42)(H,37,45)(H,43,44) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-({2-[(2-{[(azepan-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(1-methyl-1H-indol-3-yl)propylidene}amino)-3-(4-hydroxyphenyl)propanoate | HMDB |
|
|---|
| Chemical Formula | C34H45N5O6 |
|---|
| Average Molecular Weight | 619.763 |
|---|
| Monoisotopic Molecular Weight | 619.336984189 |
|---|
| IUPAC Name | 2-(2-{2-[(azepane-1-carbonyl)amino]-4-methylpentanamido}-3-(1-methyl-1H-indol-3-yl)propanamido)-3-(4-hydroxyphenyl)propanoic acid |
|---|
| Traditional Name | 2-{2-[2-(azepane-1-carbonylamino)-4-methylpentanamido]-3-(1-methylindol-3-yl)propanamido}-3-(4-hydroxyphenyl)propanoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O)C=C1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C34H45N5O6/c1-22(2)18-27(37-34(45)39-16-8-4-5-9-17-39)31(41)35-28(20-24-21-38(3)30-11-7-6-10-26(24)30)32(42)36-29(33(43)44)19-23-12-14-25(40)15-13-23/h6-7,10-15,21-22,27-29,40H,4-5,8-9,16-20H2,1-3H3,(H,35,41)(H,36,42)(H,37,45)(H,43,44) |
|---|
| InChI Key | JVILFANCFWZBFU-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Oligopeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-oligopeptide
- Tyrosine or derivatives
- Phenylalanine or derivatives
- Leucine or derivatives
- N-carbamoyl-alpha-amino acid or derivatives
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- Triptan
- Alpha-amino acid amide
- 3-phenylpropanoic-acid
- N-alkylindole
- 3-alkylindole
- Amphetamine or derivatives
- Alpha-amino acid or derivatives
- N-substituted-alpha-amino acid
- Indole or derivatives
- Indole
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Azepane
- Fatty acyl
- Benzenoid
- Substituted pyrrole
- N-methylpyrrole
- N-acyl-amine
- Fatty amide
- Monocyclic benzene moiety
- Heteroaromatic compound
- Pyrrole
- Urea
- Secondary carboxylic acid amide
- Carbonic acid derivative
- Carboxamide group
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 17.2857 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.69 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3450.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 181.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 252.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 165.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 229.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 767.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 635.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 112.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1437.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 691.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2083.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 438.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 452.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 203.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 93.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #1 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4747.2 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #1 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4413.3 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #1 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 6357.0 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #10 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O)[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4767.7 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #10 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O)[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4553.4 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #10 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O)[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 6550.3 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #2 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 4859.2 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #2 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 4436.3 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #2 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 6419.2 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #3 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 4856.9 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #3 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 4421.9 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #3 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 6419.0 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #4 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4798.2 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #4 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4486.1 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #4 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 6447.6 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #5 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4768.6 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #5 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4479.0 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #5 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 6419.3 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #6 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)[Si](C)(C)C | 4898.9 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #6 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)[Si](C)(C)C | 4498.8 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #6 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O[Si](C)(C)C)C=C1)C(=O)O)[Si](C)(C)C)[Si](C)(C)C | 6496.0 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #7 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4716.4 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #7 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4488.3 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #7 | CC(C)CC(C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 6472.1 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #8 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4687.4 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #8 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 4480.1 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #8 | CC(C)CC(C(=O)NC(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N(C(=O)N1CCCCCC1)[Si](C)(C)C | 6464.2 | Standard polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #9 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4806.2 | Semi standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #9 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4498.5 | Standard non polar | 33892256 | | N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,3TMS,isomer #9 | CC(C)CC(NC(=O)N1CCCCCC1)C(=O)N(C(CC1=CN(C)C2=CC=CC=C12)C(=O)N(C(CC1=CC=C(O)C=C1)C(=O)O[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 6539.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_1_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
|---|